Abbvie takes over Novo Holdings portfolio company

Syndesi Therapeutics has been acquired by Abbvie in a USD 1bn deal.

Photo: PR / Novo Seeds

After four years of ownership, Novo Holdings has decided to sell Belgian portfolio company Syndesi Therapeutics to Abbvie.

The deal may total up to USD 1bn, with a USD 130m upfront payment.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs